Hernandez G
*, Ospina-Tascón GA, Kattan E, Ibarra-Estrada M, Ramasco F, Orozco N, Ramos K, Aldana JL, Ferri G, Hamzaoui O, De Backer D, Teboul JL, Vieillard-Baron A, Petri-Damiani L, García-Gallardo GA, Morales S, Carmona-Garcia P, Mendez-Hernández R, Hernandez-Gilsoul T, Pérez-Nieto OR, Olea-Vielba C, Ramos S, Domínguez D, Bruna M, David S, Wendel-Garcia PD, Galiana-Ivars M, Myatra SN, Messina A, Cecconi M, Pozo M, Amthauer M, Higuera E, Al Duhalib Z, Rico-Feijoo J, Ferrer-Gómez C, Pérez-Carbonell A, Martinez-Castro S, Redondo-Calvo FJ, Vives M, Sanchez HF, Bilbao I, Fernandez P, Al-fares A, Benítez-Cano A, Gonzalez C, Reyes LF, Rodriguez-Guillen JH, Cristino AV, Pendino JC, Ortiz G, Alonso-Gonzalez MC, Murias G, Aguirre-Avalos G, Hernandez L, Calderón-Barajas ZA, Zarragoikoetxea I, Monnet X, Goury A, Mendonça Dos Santos T, Vallecilla L, Martins de Lima L, Sady E, Alegria L, Ostermann M, Bakker J, Biasi-Cavalcanti A, ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network, Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR), and Latin American Intensive Care Network (LIVEN).
Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. JAMA 2026; 334(22): 1988-1999.
